Señales en vivo de QNCX | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 abr 2024 @ 16:00):

Stats
Volumen de hoy	25 682.00
Volumen promedio	72 125.00
Capitalización de mercado	45.59M
EPS	$0 ( 2024-04-02 )
Próxima fecha de ganancias	( $0 ) 2024-06-05
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.260
ATR14	$0.00600 (0.57%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-15	Patni Rajiv	Buy	54 000	Employee Stock Option (right to buy)
2024-02-15	Patni Rajiv	Buy	0
2024-02-01	Ryan Charles S.	Buy	145 000	Employee Stock Option (right to buy)
2024-02-01	Hannah Brendan	Buy	600 000	Employee Stock Option (right to buy)
2024-02-01	Thye Dirk	Buy	1 500 000	Employee Stock Option (right to buy)

INSIDER POWER
90.02
Last 72 transactions
Buy: 5 607 188 \| Sell: 249 899

Volumen Correlación

Largo: -0.04 (neutral)

Corto: 0.99 (very strong)

Signal:(52.218) Expect same movement, but be aware

Quince Therapeutics, Inc. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Quince Therapeutics, Inc. Correlación - Moneda/Commodity

0.25
( neutral )

0.34
( neutral )

0.00
( neutral )

-0.19
( neutral )

-0.11
( neutral )

Quince Therapeutics, Inc. Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$-322 000 (0.00 %)
EPS:	$-0.840

FY	2023
Ingresos:	$0
Beneficio Bruto:	$-322 000 (0.00 %)
EPS:	$-0.840

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-175 000 (0.00 %)
EPS:	$-1.540

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-3.02

Financial Reports:

No articles found.

Quince Therapeutics, Inc.

Quince Therapeutics, Inc., a biopharmaceutical company, focuses on advancing precision therapeutics for debilitating and rare diseases. The company has discovered a broad bone-targeting drug platform to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease. Its lead compound is NOV004, an anabolic peptide engineered to precisely target and concentrate at the bone fracture site The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.